A novel member of the leukocyte receptor complex regulates osteoclast differentiation

Journal of Experimental Medicine

Volumn 195, Issue 2, 2002, Pages 201-209

  Kim, Nacksung ^a   Takami, Masamichi ^a   Rho, Jaerang ^a   Josien, Regis ^b   Choi, Yongwon ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Costimulation; Differentiation; Ig like receptor; Osteoclast; TRANCE

Indexed keywords

CELL RECEPTOR; COLONY STIMULATING FACTOR 1; LEUKOCYTE RECEPTOR COMPLEX; OSTEOCLAST ASSOCIATED RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL INTERACTION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; IMMUNOREGULATION; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

AMINO ACID SEQUENCE; ANIMALS; BONE REMODELING; CELL DIFFERENTIATION; CELLS, CULTURED; MICE; MOLECULAR SEQUENCE DATA; OSTEOCLASTS; RECEPTORS, CELL SURFACE; RECEPTORS, FC; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 0037148508     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20011681     Document Type: Article

References (41)

1. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
2. Bone resorption by osteoclasts
3. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse
4. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
5. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
6. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
7. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
8. Diverse roles of the tumor necrosis factor family member TRANCE in skeleton physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene
9. Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells
10. Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1 and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production
11. Interleukin-1α activates an NF-κB-like factor in osteoclast-like cells
12. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1
13. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
14. TGF-β1 and IFN-γ direct macrophage activation by TNF-α to osteoclastic or cytocidal phenotype
15. TGF-β enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF
16. Transforming growth factor-β1 (TGF-β) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment
17. Regulation of the differentiation and function of osteoclasts
18. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
19. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: Synergistic activation of differentiation, cell spreading, and fusion
20. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
21. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
22. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinases in T cells
23. Role of 1α,25-dihydroxyvitamin D3 in osteoclast differentiation and function
24. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
25. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts
26. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells
27. Paired Ig-like receptor homologs in birds and mammals share a common ancestor with mammalian Fc receptors
28. The genomic context of natural killer receptor extended gene families
29. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors
30. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
31. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor
32. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules
33. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
34. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
35. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
36. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
37. Regulation of immune responses through inhibitory receptors
38. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
39. The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity
40. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
41. A role for TGFβ1 in osteoclast differentiation and survival